share_log

AIM ImmunoTech | 3: Initial statement of beneficial ownership of securities-Director BRYAN NANCY

Apr 12, 2023 13:20
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more